Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
暂无分享,去创建一个
A. Deodhar | Tae-Hwan Kim | B. Combe | W. Maksymowych | A. Östör | J. Sieper | F. E. Van den Bosch | M. Kishimoto | P. Wung | D. van der Heijde | I. Song | Yuanyuan Duan | Y. Sui